Indications
Intramuscular use: When treatment by mouth is not practical, injectable corticosteroid therapy, including Cenolon injection, is indicated for intramuscular use in the following situations. Rheumatic disorders: as short-term add-on therapy to carry the patient through an acute episode or flare-up in acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis, including juvenile rheumatoid arthritis. Allergic states: to control severe or disabling allergic conditions that have not responded to adequate trials of conventional treatment, in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, and transfusion reactions. Dermatologic diseases: bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used together with mineralocorticoids where applicable, and in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. Gastrointestinal diseases: to carry the patient through a critical period of the disease in regional enteritis and ulcerative colitis. Hematologic disorders: acquired (autoimmune) hemolytic anemia, Diamond-Blackfan anemia, pure red cell aplasia, and selected cases of secondary thrombocytopenia. Neoplastic diseases: for the palliative management of leukemias and lymphomas. Nervous system: acute exacerbations of multiple sclerosis, and cerebral edema associated with a primary or metastatic brain tumor or with craniotomy. Ophthalmic diseases: sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions that do not respond to topical corticosteroids. Renal diseases: to induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or nephrotic syndrome due to lupus erythematosus. Respiratory diseases: berylliosis, fulminating or disseminated pulmonary tuberculosis when used together with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, and symptomatic sarcoidosis. Miscellaneous: trichinosis with neurologic or myocardial involvement, and tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy. Intra-articular use: Intra-articular or soft tissue administration of Cenolon injection is indicated as short-term add-on therapy to carry the patient through an acute episode or flare-up in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis, or osteoarthritis.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Triamcinolone Acetonide occurs as a white to cream-colored, crystalline powder having not more than a slight odor and is practically insoluble in water and very soluble in alcohol. It is a synthetic glucocorticoid corticosteroid with anti-inflammatory action. This formulation is suitable for intramuscular and intra-articular use only.Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Naturally occurring glucocorticoids (e.g. hydrocortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Synthetic analogs such as triamcinolone are primarily used for their anti-inflammatory effects in disorders of many organ systems. Triamcinolone injection has an extended duration of effect which may be sustained over a period of several weeks. Studies indicate that following a single intramuscular dose of 60 mg to 100 mg of Triamcinolone Acetonide, adrenal suppression occurs within 24 to 48 hours and then gradually returns to normal, usually in 30 to 40 days. This finding correlates closely with the extended duration of therapeutic action achieved with the drug.
Pregnancy & Breastfeeding
Pregnancy Category C. In animal studies, corticosteroids have been shown to cause birth defects when given at doses equivalent to those used in humans. For this reason, corticosteroids should be used during pregnancy only if the expected benefit to the mother outweighs the potential risk to the unborn baby. Corticosteroids taken systemically can pass into breast milk and may slow a nursing infant's growth, affect the body's natural corticosteroid production, or cause other unwanted effects. Corticosteroids should therefore be used with caution in breastfeeding mothers.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.